Poster: CLL-156: Novel CCL22 Mutations Drive Chronic Lymphoproliferative Disorder of NK Cells Through Biased GPCR Signaling
Shunsuke Kimura(St. Jude Children's Research Hospital), Charles G. Mullighan(St. Jude Children's Research Hospital), Martha-Lena Mueller(Munich Leukemia Laboratory (Germany)), Aakrosh Ratan(University of Virginia), Thomas L. Olson(University of Virginia Cancer Center), Claudia Haferlach(Munich Leukemia Laboratory (Germany)), Chunxu Qu(St. Jude Children's Research Hospital), Andrew B. Kleist(Medical College of Wisconsin), James M. Foran(Memorial Sloan Kettering Cancer Center), Manja Meggendorfer(Université Paris-Sud), Constance Baer(Munich Leukemia Laboratory (Germany)), Torsten Haferlach(Martin Luther Christian University), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Thomas P. Loughran(University of Virginia Cancer Center), Wencke Walter(Munich Leukemia Laboratory (Germany)), Ilaria Iacobucci(St. Jude Children's Research Hospital), Kristine C. Olson(Pennsylvania State University), HeeJin Cheon(California University of Pennsylvania), David J. Feith(University of Virginia), Elisabeth Paietta(Montefiore Medical Center), Laura J. Janke(St. Jude Children's Research Hospital), Mitra S. Rana(St. Jude Children's Research Hospital), M. Madan Babu(St. Jude Children's Research Hospital), Ravi Kalathur(St. Jude Children's Research Hospital)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k